Quantcast
Connect with us

Drug makers are jacking up prices months after Trump boasted they were rolling them back at his request

Published

on

Big Pharma companies are announcing that they are jacking up drug prices just months after President Donald Trump took to Twitter and boasted that they would roll them back or hold them down at his request.

Just as car manufacturers are shuttering plants after Trump claimed that he was responsible for a surge in manufacturing jobs, drug manufacturers such as Pfizer and Merck announced this week that they will increase pricing — contrary to Trump’s promise of price decreases.

ADVERTISEMENT

According to business columnist Micheal Hiltzik of the Los Angeles Times, the manufacturers pulled a fast one when they told Trump they would defer planned price increases back in May, only to drop the bomb before the end of the year.

On July 10th, Trump tweeted: “Just talked with Pfizer CEO and @SecAzar on our drug pricing blueprint. Pfizer is rolling back price hikes, so American patients don’t pay more. We applaud Pfizer for this decision and hope other companies do the same. Great news for the American people!”

But industry observers point out that Trump lied when he bragged about prices “rolling back.”

ADVERTISEMENT

As Hiltzik writes, “Instead, the company said it would ‘defer’ price increases on 41 drug formulations it had scheduled for July 1 until either Trump’s ‘blueprint to lower drug prices’ went into effect or the end of the year, whichever came sooner.”

He points out that Peter Maybarduk of advocacy group Public Citizen noted at the time, “Pfizer is only deferring price increases — not canceling them, and certainly not lowering its prices.”

According to University of Pittsburgh pharmaceutical policy expert Walid Gellad, drug companies humored the president while making plans to go ahead with raising prices after getting kudos from Trump.

ADVERTISEMENT

“Making promises to the president is not how you fix a fundamental market problem,” Gellad explained.

The Times report notes that Merck manipulated public opinion — and possibly the president — by playing fast and loose with the truth.

“Merck, in its July 20 announcement of price cuts, built itself a rather more elaborate loophole. The company said it would not increase the average net price of its entire portfolio of drugs by more than inflation annually,” Hikltzik wrote. “It dressed up the announcement by lowering the price of Zepatier, a hepatitis C treatment, by 60% and of six other drugs by 10%.”

ADVERTISEMENT

He then noted that the seven drugs listed were small, unpopular and unprofitable formulations that account for very little of their sales, writing, “Zepatier sales had fallen so low by the first quarter of this year that Merck listed the drug’s U.S. sales in its quarterly financial report as essentially zero.”

Addressing just Merck’s announced increase, and using its 2017 revenues as a guide, Hiltzik said the announced increases “will fatten Merck’s profits by about $357 million, or 15%.”

You can read more here.

ADVERTISEMENT

Enjoy this piece?

… then let us make a small request. Like you, we here at Raw Story believe in the power of progressive journalism — and we’re investing in investigative reporting as other publications give it the ax. Raw Story readers power David Cay Johnston’s DCReport, which we've expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and legal efforts to harm workers exploited by abusive bosses. We’ve launched a weekly podcast, “We’ve Got Issues,” focused on issues, not tweets. And unlike other news outlets, we’ve decided to make our original content free. But we need your support to do what we do.

Raw Story is independent. You won’t find mainstream media bias here. We’re not part of a conglomerate, or a project of venture capital bros. From unflinching coverage of racism, to revealing efforts to erode our rights, Raw Story will continue to expose hypocrisy and harm. Unhinged from billionaires and corporate overlords, we fight to ensure no one is forgotten.

We need your support to keep producing quality journalism and deepen our investigative reporting. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us in the future. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you. Click to donate by check.

Enjoy this piece?

… then let us make a small request. Like you, we here at Raw Story believe in the power of progressive journalism — and we’re investing in investigative reporting as other publications give it the ax. Raw Story readers power David Cay Johnston’s DCReport, which we've expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and efforts to harm workers exploited by abusive bosses. We’ve launched a weekly podcast, “We’ve Got Issues,” focused on issues, not tweets. Unlike other news sites, we’ve decided to make our original content free. But we need your support to do what we do.

Raw Story is independent. You won’t find mainstream media bias here. We’re not part of a conglomerate, or a project of venture capital bros. From unflinching coverage of racism, to revealing efforts to erode our rights, Raw Story will continue to expose hypocrisy and harm. Unhinged from corporate overlords, we fight to ensure no one is forgotten.

We need your support to keep producing quality journalism and deepen our investigative reporting. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us in the future. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you.



Report typos and corrections to: [email protected]. Send news tips to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Twitter mocks ‘gibbering conspiracy loon’ Trump after he claims Google rigged the election

Published

on

On Monday, President Donald Trump made the dubious claim that Google had tried to sway the election for Hillary Clinton.

"My victory was even bigger than thought!" the president proclaimed.

Wow, Report Just Out! Google manipulated from 2.6 million to 16 million votes for Hillary Clinton in 2016 Election! This was put out by a Clinton supporter, not a Trump Supporter! Google should be sued. My victory was even bigger than thought! @JudicialWatch

— Donald J. Trump (@realDonaldTrump) August 19, 2019

Continue Reading

Breaking Banner

Paul Krugman hilariously roasts Trump economic adviser for decades’ worth of terrible predictions

Published

on

Nobel Prize-winning economist Paul Krugman on Monday set his sights on Trump economic adviser Larry Kudlow, who himself is not actually an economist, for making decades' worth of terrible predictions.

Writing on Twitter, Krugman concedes that making predictions is a difficult business and he admits to making his own bad predictions in the past.

However, he then explains that Kudlow is unique because he's been making the same false prediction for decades -- namely, about tax cuts for the ultra-rich producing economic miracles.

Continue Reading
 

Breaking Banner

Twitter admits China has created hundreds of fake accounts to undermine Hong Kong protests

Published

on

Twitter on Monday admitted that China had created hundreds of fake accounts aimed at undermining the protests in Hong Kong that have gripped the city in recent weeks.

Specifically, Twitter found that at least 936 different accounts had been created within the People's Republic of China that have been "deliberately and specifically attempting to sow political discord in Hong Kong, including undermining the legitimacy and political positions of the protest movement on the ground."

Continue Reading
 
 

Thank you for whitelisting Raw Story!

As a special thank you, from now until August 31st, we're offering you a discounted rate of $5.99/month to subscribe and get ad-free access. We're honored to have you as a reader. Thank you. :) —Elias, Membership Coordinator
LEARN MORE
close-link
close-image